Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Giovanni Dolci and Giovanni Guaraldi.
Giovanni Dolci
Connection Strength
1.220
Giovanni Guaraldi
  1. Darunavir/Cobicistat Is Associated with Negative Outcomes in HIV-Negative Patients with Severe COVID-19 Pneumonia. AIDS Res Hum Retroviruses. 2021 04; 37(4):283-291.
    View in: PubMed
    Score: 0.234
  2. Methylprednisolone as rescue therapy after tocilizumab failure in patients with severe COVID-19 pneumonia. Clin Exp Rheumatol. 2021 Sep-Oct; 39(5):1141.
    View in: PubMed
    Score: 0.233
  3. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatol. 2020 Aug; 2(8):e474-e484.
    View in: PubMed
    Score: 0.222
  4. Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection. Open Forum Infect Dis. 2017; 4(2):ofx065.
    View in: PubMed
    Score: 0.180
  5. Late presentation increases risk and costs of non-infectious comorbidities in people with HIV: an Italian cost impact study. AIDS Res Ther. 2017 Feb 16; 14(1):8.
    View in: PubMed
    Score: 0.176
  6. The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study. PLoS One. 2021; 16(8):e0251378.
    View in: PubMed
    Score: 0.060
  7. The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients. PLoS One. 2021; 16(5):e0251768.
    View in: PubMed
    Score: 0.059
  8. Abdominal Visceral Infarction in 3 Patients with COVID-19. Emerg Infect Dis. 2020 Aug; 26(8):1926-1928.
    View in: PubMed
    Score: 0.055
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.